Home

Genomic Valley Biotech Ltd EPS

Image

Genomic Valley Biotech Ltd

NSE: GENOMICVALLEY

EPS

₹ 1.26

Last updated on: Apr 17, 2025

Key Highlights

  • The Earning per Share of Genomic Valley Biotech Ltd is ₹ 1.26 as of 17 Apr 25 .
  • The earning per share of Genomic Valley Biotech Ltd changed from ₹ 0.09 to ₹ 0.51 over 7 quarters. This represents a CAGR of 169.45% .

Historical Earning per Share of Genomic Valley Biotech Ltd

No data available

* All values are in

Company Fundamentals for Genomic Valley Biotech Ltd

Market Cap

19 Cr

EPS

1.3

P/E Ratio (TTM)

50.1

P/B Ratio (TTM)

5.1

Day’s High

63.34

Day’s Low

62.1

DTE

0.0

ROE

6.6

52 Week High

108.15

52 Week Low

28.36

ROCE

6.6

Market Price of Genomic Valley Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Genomic Valley Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
17 Apr 202563.13
16 Apr 202562.1
15 Apr 202562.07
11 Apr 202560.3
09 Apr 202558
08 Apr 202555.37
07 Apr 202552.75
04 Apr 202550.24
03 Apr 202552.25
02 Apr 202555

BlinkX Score for Genomic Valley Biotech Ltd

Asset Value vs Market Value of Genomic Valley Biotech Ltd

Market Value

19

Asset Value

Value addition

5.6 X

3

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Genomic Valley Biotech Ltd19.28
GMR Airports Ltd91335
OneSource Specialty Pharma Ltd17918
International Gemmological Institute (India) Ltd15264
Embassy Developments Ltd12647
Rites Ltd11225

Historical Market Cap of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Genomic Valley Biotech Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Genomic Valley Biotech Ltd News Hub

Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter

Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 20

Read more

08 Oct 24

Genomic Valley Biotech to discuss results

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 October 202

Read more

03 Oct 24

Genomic Valley Biotech to convene board meeting

Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2

Read more

11 Feb 25

Genomic Valley Biotech schedules AGM

Genomic Valley Biotech announced that the Annual General Meeting(AGM) of the company will be held on

Read more

07 Dec 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Genomic Valley Biotech Ltd

What is the EPS of Genomic Valley Biotech Ltd stock?

The Earnings Per Share (EPS) of Genomic Valley Biotech Ltd is 1.26. An EPS is the amount of net income attributed to each share of a common stock.

How is Genomic Valley Biotech Ltd EPS calculated?

The EPS of Genomic Valley Biotech Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Genomic Valley Biotech Ltd report its EPS?

Genomic Valley Biotech Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Genomic Valley Biotech Ltd EPS?

Factors that influence the EPS of Genomic Valley Biotech Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Genomic Valley Biotech Ltd EPS growth indicate future performance?

Yes, consistent growth in Genomic Valley Biotech Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions